Medyra’s primary manufacturing facility is located in Baddi, Himachal Pradesh, a hub of industrial activity, especially in the pharmaceutical sector. Our Baddi plant is equipped with cutting-edge infrastructure, designed to handle large-scale production across a variety of formulations, including oncology drugs in the form of liquid vials, tablets, capsules, and lyophilized products.

● Land Area: 2252 sq. meters, housing modern facilities that enable us to manufacture over 200 formulations.
● Liquid Vial Filling: Our Indian operations have the capacity to fill 2 ml to 50 ml vials, producing up to 12 million vials annually. This includes formulations for oncology drugs that demand the highest standards of sterility and precision.
● Lyophilization (Freeze Drying): Capable of lyophilizing 2 ml to 50 ml vials, with a total capacity of 1 million vials per year.
● Tablets and Capsules: The facility can manufacture 30 million tablets and 20 million capsules annually, ensuring mass production of high-demand medications.
● Quality Assurance: We have in-house quality control labs for microbiology and analytical testing, ensuring that every batch meets stringent international standards.

Our Indian manufacturing operations reflect Medyra’s dedication to providing affordable and accessible treatments for cancer patients, both domestically and globally. The facility is equipped to innovate and scale production, responding swiftly to market demands and regulatory requirements. By continually investing in advanced technologies and R&D, we are able to innovate and scale production efficiently, keeping pace with the global demand for oncology solutions.

With a foundation built on innovation, precision, and a commitment to global health, Medyra Pharmaceutical is not just manufacturing medicines—we’re shaping the future of oncology care. Every vial, tablet, and capsule we produce is a step closer to giving patients a fighting chance, wherever they are in the world.